METiS TechBio’s blockbuster IPO signals rising investor interest in AI startups focused on how drugs are delivered inside the body
Updated
May 14, 2026 3:02 PM
HIV-1 virus particles, coloured red. PHOTO: UNSPLASH
Investors are beginning to place bigger bets on AI startups focused on drug delivery infrastructure rather than drug discovery alone. That shift was on display this week after METiS TechBio, a Hong Kong tech-bio startup focused on AI-powered drug delivery systems, debuted on the Hong Kong Stock Exchange.
The listing made METiS TechBio the world’s first publicly traded AI-powered drug delivery startup and the first AI-powered large-molecule biopharmaceutical startup listed in Hong Kong. The startup raised more than HKD 2.1 billion through its IPO, making it the largest healthcare listing in Hong Kong so far in 2026.
Investor demand was unusually strong. The Hong Kong public offering was oversubscribed by more than 6,900 times while the international tranche recorded 82 times oversubscription. More than 280 institutional investors participated in the international placing.
The strong demand reflects a wider shift in AI biotech. Over the past few years, much of the sector’s attention has focused on using AI to discover new drugs or molecules. METiS is taking a different approach. The startup focuses on how medicines are delivered inside the body after they are developed.
That challenge is becoming harder to ignore in biotech. Designing a therapy is only one part of the process. Delivering it precisely to specific organs, tissues or cells remains a major hurdle, especially for newer therapies involving RNA, proteins and large-molecule drugs.
METiS is trying to solve that problem through its proprietary NanoForge platform. The system uses AI to design and test nanodelivery systems that help medicines reach targeted areas inside the body more efficiently. The platform combines AI models, simulation systems and high-throughput screening tools to speed up formulation development and improve delivery precision.
The startup says it has already achieved targeted delivery across eight organs and tissue systems including the liver, lungs, heart, muscles and central nervous system.
One of its lead programs, MTS-004, became China’s first AI-enabled formulation drug to complete a Phase III clinical trial. The drug is being developed for pseudobulbar affect, a neurological condition that affects emotional expression. According to the startup, AI tools helped reduce preclinical formulation development time from up to two years to less than three months.
Investor interest in the IPO also came from some of the world’s largest asset managers and healthcare funds. BlackRock led the cornerstone investments with a USD 50 million subscription. Other participating investors included UBS Asset Management Singapore, Mirae Asset, ORIX Corporation, Deerfield, RTW, Hillhouse Capital and IDG Capital.
METiS is also building what it describes as a “platform collaboration + product partnership” business model. The startup currently works with more than 30 pharmaceutical and biotechnology partners globally, including large pharmaceutical companies and medical research institutions.
The company reported RMB 105 million in revenue in 2025, largely tied to upfront payments connected to its MTS-004 partnership agreements. It also said some platform collaboration contracts could reach milestone values of up to USD 109 million.
Chris Lai said: "The future of biomedicine will no longer be simply about 'taking medicine when one falls ill.' METiS TechBio's ambition is to harness AI to build nano-rockets that can navigate with precision through the inner space of the human body's 30 trillion cells, write the code of nucleic acids and proteins into cells, and reprogram diseased and aging cells into healthy cells. This was our founding aspiration, and it is the mission to which we will dedicate our lives. The IPO marks a new starting point for us to accelerate forward, and we will strive to live up to the support and trust we have received from all sectors."
The IPO also highlights how Hong Kong is increasingly positioning itself as a hub for next-generation biotech and AI healthcare startups. While investor excitement around AI drug discovery has cooled in parts of the market, startups focused on delivery systems and biotech infrastructure are beginning to attract stronger institutional backing.
For METiS, the challenge now will be turning that investor confidence into commercially viable therapies and long-term partnerships. But the listing suggests that AI-driven drug delivery is starting to emerge as a category investors are willing to treat as core biotech infrastructure rather than a niche research experiment.
Keep Reading
A smartphone that moves, tracks and responds in real time—but is it real utility or just a marketing gimmick?
Updated
May 1, 2026 2:25 PM
HONOR Robot Phone, with its camera arm extended. PHOTO: HONOR
Smartphones today feel more familiar than new. Each year brings better performance and better cameras, but fewer real surprises. So when a company unveils something called a “Robot Phone”, it’s bound to get attention.
HONOR did exactly that at the Mobile World Congress (MWC) in Barcelona this year. While most smartphone brands are focused on software upgrades, HONOR is trying something different with hardware. Its Robot Phone is built to move and adjust on its own. The camera sits on a motorized system that can tilt, track motion and shift angles automatically. It almost looks like a small robotic head, following whatever is happening in front of it. It can pick up sound, recognize motion and stay visually aware of its surroundings. This result feels less like using a regular phone and more like interacting with something responsive.
So what makes HONOR’s Robot Phone different from the smartphones we already use? Here’s a closer look at its camera system, AI features and design, and whether it is truly something new or simply smart marketing.
At its core, the Robot Phone still works like a regular smartphone. What makes it different is the camera system. It has a 200MP camera that sits on a motorized arm with a three-axis gimbal, which extends when in use and folds back into the phone when not needed. The compact motor gives the camera physical movement, while motion control allows it to sense, track and follow a person or object in real time. That means it can keep a subject in frame without constant manual adjustment.
The camera also adds a more playful side to the experience. It can respond with simple gestures, such as nodding or shaking its head, and it can even move in sync with music.
This setup could be particularly useful for content creators. As CNET tech journalist and YouTuber Andrew Lanxon pointed out, it removes the need to carry a separate gimbal. Since the robotic camera module can easily fold into the body of the phone, it is easier to carry around and more convenient for filming or taking photos on the go.
The Robot Phone also has the practical advantage of a smartphone display. It gives users a bigger screen than a standalone camera for framing, monitoring and reviewing footage. Since it runs on Android, the process of recording, editing and sharing content is also more direct.
The most impressive part of the HONOR Robot Phone design is how it fits a moving camera system into the body of a smartphone without needing external attachments.
To make this possible, HONOR uses a custom micro motor that is 70% smaller than mainstream competitors. The company also says it is the industry’s smallest four-degrees-of-freedom (4DoF) gimbal system. To support the stable movement of the camera module, the internal structure uses high-strength materials such as steel and titanium alloy. These materials help the mechanism stay durable as it shifts and repositions over time.
Battery life is another obvious question. HONOR has not revealed the battery capacity of the Robot Phone itself, but it did showcase its Silicon-Carbon Blade Battery technology at MWC 2026. The company says this battery is designed to increase energy density while keeping devices slim, and that it could support capacities of 7,000 mAh and beyond in future foldable devices.
That is not specific to the Robot Phone, but it does hint at the kind of battery improvements that may be needed for smartphones with moving parts and more advanced camera systems.
The AI features in Honor’s Robot Phone are focused on how the device sees and responds to its surroundings in real time. At the most basic level, the phone can track what is happening in a scene and adjust itself without constant user input.
On the functional side, the system keeps subjects framed and in focus automatically. Its AI Object Tracking ensures subjects stay centred, while AI SpinShot enables controlled 90° and 180° rotations for smoother transitions, even when the phone is used one-handed. It can also detect motion and recognize sound, which lets it respond to activity as it happens instead of reacting frame by frame.
The AI becomes more noticeable in the way the device behaves. When activated, the camera module unfolds and the screen displays a pair of animated eyes that track the user’s face and gaze. Honor calls this “embodied AI”, meaning the assistant expresses itself through movement rather than only voice or text. The camera module can adjust its angle during video calls, which makes it feel a little more physically present.
According to Thomas Bai, AI product expert at Honor, the goal is to move beyond passive assistance. By combining sensing, movement and real-time processing, the device is designed to interact with its environment in a more continuous way. In practice, that could mean interpreting its surroundings and responding as situations change, such as when someone is moving through an unfamiliar space.
The Robot Phone has sparked curiosity, but there is still a lot we do not know. For one thing, it is still a prototype, with a release expected later this year. Early signs also suggest it may be expensive, partly because of rising memory chip costs. Some of its more playful features also feel uncertain. In demos, the phone can move along to music, but with only a handful of pre-set tracks, it is hard to tell whether that feature will be genuinely useful or remain more of a showcase moment.
Then there are the practical questions. A motorized camera system could make the phone heavier and more top-heavy, which may affect comfort during daily use. Running a motor alongside continuous AI tracking will also likely put pressure on battery life. These are not dealbreakers, but they are trade-offs that will matter outside of a demo.
Privacy is another concern that is hard to overlook. Some of the AI features rely on cloud processing, which means certain data is sent to external servers instead of being processed fully on the device. That is common in many AI systems today, but it feels more significant here because the phone is built to actively track movement and reposition its camera in real time. For some people, that level of autonomy may feel intrusive rather than helpful. It also raises bigger questions about what sensors are built into the device and how much data they collect during everyday use.
So, is the HONOR Robot Phone a real step forward, or just a clever idea packaged well?
The answer depends on who it is for.
For content creators, the appeal is obvious. Early indications suggest it could make video capture easier by reducing the need for extra gear. Honor’s collaboration with cinema camera company ARRI also suggests a serious push toward more cinematic smartphone footage.
For everyone else, the value is less clear. Outside of content creation, it is still hard to see how these features would translate into everyday use in a meaningful way.
For now, the Robot Phone sits somewhere between promise and experiment. Whether it turns into a genuinely useful new kind of smartphone or fades away as a novelty will only become clear once it moves beyond controlled demos and into real life.